Search Results
In the News
Ubrogepant Sustains Efficacy, Safety in Combination With OnabotulinumtoxinA
June 11, 2022
In the News
The MiCOAS Project and the Importance of Patient-Reported Outcomes in Migraine
June 10, 2022
In the News
Rimegepant Is Well-Tolerated and Safe for Migraine Over 1 Year With Every-Other-Day Dosing
June 10, 2022
In the News
Free Screenings for Prevention and Early Detection of Breast Cancer at Yonkers Public Library
June 6, 2022
In the News
Gender-Affirming Care for Pediatric and Adolescent Youth, Pride in Our Kids
June 4, 2022